MedTech World: Fueling MedTech Investment Momentum Across Borders
In 2024, California’s medtech sector defied expectations and exceeded previous funding benchmarks. According to the J.P. Morgan Medtech Industry insights, a staggering $19.1 billion was raised across 691 funding rounds, surpassing 2023’s figures despite a drop in deal volume. Instead, investors shifted their focus toward fewer but more substantial investments, prioritizing quality and long-term growth potential. Alongside this, the M&A landscape flourished with 305 acquisitions totalling $63.1 billion, largely driven by smaller, strategic deals. The IPO front, too, is regaining its footing with $744.5 million raised through four medtech IPOs. Particularly promising are AI-powered diagnostics and personalized medicine startups that continue to generate optimism on the public markets.
Southern California remains a powerhouse within this investment surge, generating over $20 billion in annual revenues. Its medtech ecosystem is known for its capacity to produce strong shareholder returns and foster innovation at scale. This dynamic environment reflects broader industry trends: a more mature, measured, and innovation-focused investment cycle.
Amid this flourishing investment activity, MedTech World is positioning itself as the international gateway that brings together the most relevant stakeholders in the sector, from startup founders and academic leaders to investors and global health authorities. Its growing global footprint and emphasis on meaningful engagement have cemented its place as a connector of high-potential companies and visionary backers.
Connecting Innovation with Capital: The Role of MedTech World
MedTech World’s approach is rooted in creating deliberate connections across geographies and specialisations. In a year where funding growth has increasingly relied on large-scale, targeted investment, the need for a trusted, curated platform for introductions and dialogue has never been greater. With that in mind, MedTech World has partnered with MedTech Innovator for an exclusive event taking place on June 27th in San Jose, California.
This event brings together 100 carefully selected startups and a robust network of investors and key industry figures, creating the ideal environment for substantive conversation and deal-making. MedTech Innovator, the world’s largest accelerator for medical device, digital health, and diagnostics companies, is known for propelling transformative healthcare ventures. Together, the partnership exemplifies what MedTech World has consistently championed, platforms that connect innovative ideas with the resources they need to scale, sustainably and globally.
But MedTech World’s efforts aren’t confined to North America. Earlier this year, at its Dubai edition, the platform collaborated with AmCham Dubai to encourage cross-border investment between the U.S. and the GCC region. This event opened up new channels for emerging technologies and underscored the platform’s role in fostering dialogue between historically underconnected markets. By bridging these gaps, MedTech World contributes not just to investment but also to the globalisation of healthcare innovation.
“At MedTech World, we’ve always believed that opportunity isn’t bound by geography. Whether in California, Dubai, or Malta, our mission is to build an ecosystem where investors and startups don’t just meet, they build meaningful partnerships. As the industry becomes more complex, curated spaces like ours help stakeholders navigate risk, identify transformative potential, and build long-term value. We are proud to work alongside global partners to create events that are not only relevant but also future-facing.” Dr. Dylan Attard, CEO and Co-founder, MedTech World
Looking Ahead: Why Investors Should Turn Their Eyes to Malta
The major touchpoint in MedTech World’s calendar is MedTech Malta 2025, taking place from 12 to 14 November. Set against the backdrop of Malta’s growing reputation as a hub for innovation, this flagship event offers a compelling opportunity for investors to engage with promising startups, participate in strategic discussions, and expand their networks across continents.
Malta’s strategic location between Europe, Africa, and the Middle East provides a unique convergence point for international delegates. For investors, it presents a rare opportunity to evaluate cross-border deals and gain visibility into MedTech trends emerging from diverse markets. The event will include keynote sessions, investor roundtables, and startup showcases tailored to facilitate dialogue and action, in addition to the MedTech startup pitch competition.
As global interest in healthcare technology continues to rise, investors need platforms that offer more than exposure; they need relevance, curation, and access. MedTech World continues to deliver just that.
